Back to Search
Start Over
Efficacy and Safety of Ticagrelor for Long-term Secondary Prevention of Atherothrombotic Events in Relation to Renal Function: Insights from the PEGASUS TIMI-54 trial
- Publication Year :
- 2016
- Publisher :
- Università di Parma. Dipartimento di Medicina Clinica e Sperimentale, 2016.
-
Abstract
- Aims: We evaluated the relationship of renal function and ischaemic and bleeding risk as well as the efficacy and safety of the P2Y12 platelet receptor inhibitor ticagrelor in stable patients with prior myocardial infarction (MI). Methods & Results: Patients with a history of MI 1-3 years prior from the Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)-TIMI 54 were stratified based on estimated glomerular filtration rate (eGFR), with
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.od.......341..b32147bb196ff5fa8293a0ef73d974ee